NCT02165111: Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome |
|
|
| Completed | 3 | 40 | US | Onabotulinumtoxin A, Botox, Botulinum toxin, Dysport, sterile saline solution, Saline | Johns Hopkins University, Allergan | Scleroderma, Raynaud's Syndrome | 09/15 | 09/15 | | |
